Hosted on MSN

FDA opens fast-track program to speed US drug plant construction

The U.S. Food and Drug Administration started taking applications for its PreCheck pilot, a new effort to accelerate the construction and review of pharmaceutical manufacturing facilities in the ...

Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate

ACAD wins FDA's Fast Track status for remlifanserin in Alzheimer's disease psychosis as its phase II data readout approaches ...

Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma

Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that ISM6331, a novel, potential best-in-class ...
GlobalData on MSN

FDA grants fast track designation for HAYA Therapeutics’ HTX-001

HTX-001 has not received approval from the FDA, European Medicines Agency, or any other regulatory authority.

Hopstem Receives U.S. FDA IND Clearance and Fast Track designations for hNPC01 in Hemorrhagic Stroke and Traumatic Brain Injury-Expanding Clinical Development Across Three ...

Hopstem Biotechnology announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application and Fast Track designations for hNPC01 , an allogeneic ...

Nektar gets FDA fast track status for alopecia areata drug

Nektar Therapeutics (NASDAQ:NKTR) has announced that the FDA has awarded Fast Track designation to its experimental drug rezpegaldesleukin, a treatment for severe-to-very severe alopecia areata. This ...
News-Medical.Net

FDA grants fast track designation to Insilico's AI-designed mesothelioma drug candidate

Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that ISM6331, a novel, potential best-in-class ...
Cure Today

Pelareorep Receives FDA Fast Track Status for KRAS-Mutant Colorectal Cancer

FDA fast track designation supports development of pelareorep plus bevacizumab/FOLFIRI in 2L KRAS-mutant MSS mCRC, enabling more frequent regulatory engagement and potential accelerated pathways.
Morningstar

4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis

FDA Fast Track Designation granted to 4P004 for the treatment of knee osteoarthritis, recognizing the disease as a serious condition with significant unmet medical need Designation supports enhanced ...
Nasdaq

MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day

The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...
Cure Today

FDA Fast Tracks LBL-034 in Relapsed or Refractory Multiple Myeloma

LBL-034, a GPRC5D/CD3 bispecific antibody, was developed using the proprietary LeadsBody platform, featuring a unique two-to-one structure and conditional activation. Fast track designation offers ...
Seeking Alpha

FDA opens fast-track program to speed U.S. drug plant construction

The U.S. Food and Drug Administration started taking applications for its PreCheck pilot, a new effort to accelerate the construction and review of pharmaceutical manufacturing facilities in the ...